Business Wire

Almirall at the JPMorgan Conference - Entering a New Era of Sustained Growth

Share

Almirall, a global pharmaceutical company dedicated to medical dermatology, is participating in the 2025 JPMorgan HealthCare Conference to provide an update on its business strategy and outlook. The company’s CEO and president Carlos Gallardo will highlight a new era for its business starting in 2025 – forecasting sustained double-digit growth of net sales (CAGR 2023-2030) and a substantial margin expansion, driven by Almirall’s focus on medical dermatology, commercial excellence, and its continued investment in R&D to innovate and advance science.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113044812/en/

Almirall HQ in Barcelona (Photo: Business Wire)

Almirall combines the strengthening of its growth drivers, particularly the biologics products, with the continued growth of its broad portfolio of medical dermatology solutions, including Klisyri®, Wynzora®, and Seysara®. Almirall’s commercial excellence has been demonstrated by the successful launches of biologics across key markets in Europe. The success of the key growth drivers of Almirall has enabled the company to adjust the anticipated peak sales figures for the biologics portfolio to more than 800MM Eur annually comprising of expected peak sales for Ebglyss® of above 450MM Eur, and Ilumetri® of above 300MM Eur.

This development sees Almirall at a turning point entering an era of sustained double-digit growth (net sales CAGR 2023-2030) that is enabled by the previous investments into commercial capabilities for the launch of breakthrough assets, into capabilities, expertise, and infrastructure. This growth will mainly be driven by biologics which are well placed to take significant market share in these segments that show sustained overall increase and a transition of more patients to advanced treatment options.

Importantly, Almirall will continue to invest in its leading R&D capabilities in medical dermatology driving science leadership and enabling the company to develop disruptive and innovative products that build sustainable future growth as a leader in medical dermatology.

Medical Dermatology: Significant unmet needs and growth potential

Medical dermatology continues to be a pharmaceutical sector with significant unmet needs based on the severe patient impact of a wide range of dermatological diseases, the many uncontrolled patients with chronic diseases, increasing numbers of diagnoses, and the transition of more patients to advanced treatments. Almirall has significant potential for growth in this sector due to its dedication to medical dermatology, commercial capabilities, close collaboration with the medical community, and its proven end-to-end capabilities across the entire value chain. This enables Almirall to give patients and the medical community access to innovative and relevant solutions and contribute to improving their lives.

The company has continuously invested around 12% of its Net Sales in R&D over many years, laying the foundation for continued growth and acceleration in the future and creating and advancing a strong pipeline in key areas, both in clinical and preclinical stages.

Almirall has a broad range of collaborations that help to advance science and enable the development of disruptive new treatments across different modalities. The company continues to focus on building collaborations with partners that have new platforms and technologies to further develop its innovative pipeline. We access the latest available technologies, including small molecules, biologics, and other modalities such as mRNA, for example through the multi-target alliance with etherna to discover and develop innovative and disruptive mRNA / LNP therapies.

"2025 is a turning point for Almirall as we are entering an era of sustained double-digit growth of our net sales CAGR to 2030, and increased EBITDA margins to around 25% by 2028. We are dedicated to improving patients' lives and advancing medical dermatology through our leading research and development initiatives and giving patients access to novel and impactful treatment options – now and in the future," stated Carlos Gallardo, CEO and President of Almirall. "We continue with our sustained investment in R&D to lead science, innovation and excellence in medical dermatology. Almirall is a partner of choice for dermatologists and together we will impact more patients' lives in line with our company’s growth.

Our robust financial situation enables us to invest in long-term growth opportunities which are aligned with our business strategy and ambition as leaders in medical dermatology. By building on our strong portfolio, and making strategic investments, we are well-positioned to meet our ambitious objectives and generate long-term value for shareholders. Our primary advantage lies in our collaborative mindset, agility, and ability to seize opportunities swiftly. This approach also allows us to distribute development costs efficiently,” stated Mike McClelllan, Almirall's CFO.

About Almirall

Almirall is a global pharmaceutical company dedicated to medical dermatology. We closely collaborate with leading scientists, healthcare professionals, and patients to deliver our purpose: to transform the patients' world by helping them realize their hopes and dreams for a healthy life. We are at the forefront of science to deliver ground-breaking, differentiated medical dermatology innovations that address patients´ needs.

Almirall, founded in 1944 and headquartered in Barcelona, is publicly traded on the Spanish Stock Exchange (ticker: ALM, total revenue in 2023: €898.8 MM, 1900 employees globally). Almirall products help to improve the lives of patients every day and are available in over 100 countries.

For more information, please visit almirall.com

Disclaimer

This document includes only summary information and does not intend to be comprehensive. Facts, figures and opinions contained herein, other than historical, are "forward-looking statements". These statements are based on currently available information and on best estimates and assumptions believed to be reasonable by the Company. These statements involve risks and uncertainties beyond the Company's control. Therefore, actual results may differ materially from those stated by such forward-looking statements. The Company expressly disclaims any obligation to review or update any forward-looking statements, targets or estimates contained in this document to reflect any change in the assumptions, events or circumstances on which such forward-looking statements are based unless so required by applicable law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250113044812/en/

Contacts

Corporate Communications:
corporate.communication@almirall.com
Phone: (+34) 659 614 173

Investor Relations:
investors@almirall.com
Phone: (+34) 93 291 30 87

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

JT Group Recognized on CDP’s “Climate Change A List” For the 6th Consecutive Year12.2.2025 08:30:00 EET | Press release

Japan Tobacco Inc. (JT) (TSE: 2914) has been recognized for its leadership in corporate sustainability by the global environmental non-profit organization CDP, for the sixth year in a row. The JT Group is one of the companies to be included on the Climate Change A List, out of more than 24,800 companies participating in the 2024 CDP environmental disclosure program. The JT Group achieved a place on CDP's prestigious "A List" for tackling climate change for the sixth consecutive year. We believe that as nature, society, and people’s lives are intertwined, sustaining our ways of living, and the activities of corporate entities, will depend on the sustainability of the environment and societies in which we live. In pursuing the 4S model, JT Group’s management principle, and by realizing the JT Group Purpose, the Company ensures to contribute to the sustainability of the environment and society, through its commitment to working on the material issues identified. As a part of the ecosystem

Inaugural Dealroom and NATO Innovation Fund Report Reveals Record-Breaking Investing in Startups in European Defence, Security, and Resilience Sector12.2.2025 07:05:00 EET | Press release

Dealroom.co and the NATO Innovation Fund - a €1 billion VC (Venture Capital) backed by 24 NATO countries – published today their inaugural report on the state of Defence, Security and Resilience in Europe, revealing a record-breaking year for investing in this segment. This highlights the critical role that the sector is playing in maintaining Europe’s technological edge and sovereignty amidst a broader market downturn. Key findings from the report reveal: VC funding in the DSR (defence, security and resilience) sector is at an all-time high, reaching $5.2 billion in 2024. Overall, investing is up nearly 5x in the last six years. With companies in early and breakout stages driving this growth, a strong pipeline to scaling is expected in the coming years. DSR investing has increased by 30 percent over the past two years - the strongest growth among all VC deep tech segments. The segment has significantly outperformed the overall VC market, which witnessed a 45 percent decline in the sam

Klook Closes $100 Million Investment to Fuel Next Decade of Travel Experiences Growth12.2.2025 04:00:00 EET | Press release

Klook, a leading platform for experiences and travel services in Asia, today announced US$100 million in funding led by the global growth investment firm Vitruvian Partners. The latest investment underscores continued confidence in Klook’s vision, market leadership, and operational excellence as the company accelerates its efforts to capture the fast-growing market of next generation travelers and deepen its reach across Asia Pacific. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250211163358/en/ Founded in 2014, Klook inspires and enables more moments of joy for travelers with curated quality experiences ranging from the biggest attractions to paragliding adventures, iconic museums to rich cultural tours, and other convenient local travel services across 2,700 destinations around the world. (Photo: Business Wire) Marking its 10th anniversary in 2024, Klook has been instrumental in redefining how travelers discover and book

Esri Developer & Technology Summit Features Expanded Program to Reflect Growth of Geospatial Development12.2.2025 00:41:00 EET | Press release

On March 11, 2025, Esri, the global leader in geographic information system (GIS) technology, is hosting the Developer & Technology Summit in Palm Springs, California. Over the past 20 years, the event—formerly known as the Esri Developer Summit—has evolved significantly to support Esri’s growing user community of developers, system architects and admins, DevOps and security engineers, and builders. This year’s attendees can look forward to an expanded range of technical content covering the latest developer tools and IT implementations. Those attending this year’s conference will learn how to: Leverage the latest Esri SDKs, open-source libraries, and data services to build cutting-edge spatial solutions. Architect and manage enterprise GIS systems to be scalable, performant, and secure. Configure custom solutions and extend and automate systems using ArcGIS Maps SDKs, scripting, APIs, and ArcGIS Location Services. Integrate ArcGIS with other technologies, such as AI, across the enterp

ProAmpac Advances Recyclable Flexible and Fibre-Based Packaging at Packaging Innovations 202511.2.2025 23:03:00 EET | Press release

ProAmpac, a leader in flexible packaging and material science, will exhibit its latest recyclable and high-performance packaging solutions at Packaging Innovations 2025, taking place February 12–13 at the NEC Birmingham. Visitors can find ProAmpac at Booth L80, where the company will highlight its latest advancements in fibre-based packaging, recyclable films, and food-to-go solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250211772764/en/ Hot Cabinet (Photo: Business Wire) "At ProAmpac, we are proud to lead the way in developing sustainable packaging solutions that meet the needs of both consumers and the environment. Our advancements in fibre-based and recyclable flexible packaging demonstrate our commitment to innovation and a circular economy," said Kristy Paulin, executive vice president of global marketing for ProAmpac. "We invite attendees to visit us at Booth L80 to explore these innovations firsthand and di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye